Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Oaktree Acquisition Corp. III Life Sciences (OACC)

OACC postpones shareholder meeting on business combination extension to October 23, 2026

Neutral Impact 3 of 5 shareholder Written later

Oaktree Acquisition Corp. III Life Sciences moved its extraordinary general meeting, which was set for October 16, 2026, to October 23, 2026, to allow more time to solicit and collect proxy votes on a proposal to extend its deadline for completing an initial business combination. The record date of September 22, 2026 is unchanged, and previously submitted proxies remain valid.

Key points

  • Extraordinary general meeting moved from October 16, 2026 to October 23, 2026, at 10:00 a.m. Eastern Time
  • Shareholders wishing to attend in person must reserve attendance with the CEO by October 21, 2026
  • Record date remains September 22, 2026; existing proxies stay valid unless revoked
  • Redemption withdrawal requests may continue to be made until the rescheduled meeting

The filing

CompanyOaktree Acquisition Corp. III Life Sciences (OACC)
Form8-K, current report
Filed with the SECOct 16, 2026, 6:04 AM ET
Accession number0001193125-26-423329

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.